Schedule 13D ownership disclosure
Amarantus Bioscience Holdings, Inc.
Security class unavailable · CUSIP: 02300U205
Event date: 2020-10-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 14,176,424
- Percent of class
- 4.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-20-000332
- Form type
- SC 13D
- Filer
- Amarantus Bioscience Holdings, Inc.
- CIK
- CIK 1424812
- Filed
- Oct 09, 2020
- Reporting period
- Oct 02, 2020
- Description
- Schedule 13D beneficial ownership